文献速递血液透析通路

透析通路出血:外科急诊中的通路挽救策略

Dialysis Access Hemorrhage: Access Rescue from a Surgical Emergency.
PubMed 文献 · Ann Vasc Surg · 2017-03-22

本研究回顾了26例慢性血液透析患者因通路出血或危及生命的出血而接受通路挽救治疗的3年经验。通过原位移植物替换、直接修复或转为自体动静脉瘘,并结合中心静脉闭塞治疗,85%的患者成功挽救通路,30天内1例死亡。结论认为多数通路出血患者可成功挽救功能通路,应考虑采用原位移植物替换策略。

要点

  • 通路出血多源于感染、管壁侵蚀和静脉高压,需紧急评估。
  • 原位移植物替换(利福平浸泡PTFE)或直接修复可挽救多数通路。
  • 合并中心静脉狭窄者可分期行腔内治疗以维持通路功能。

核心结论

  • 多数透析通路出血患者可成功挽救功能通路,原位移植物替换策略应考虑用于此类外科急诊。

研究设计与样本

  • 回顾性研究,纳入2012-2014年3年间26例慢性血液透析患者(女14例,男12例),因通路出血(18例)或危及生命的出血(8例)接受治疗。

主要发现

  • 26例中22例(85%)成功挽救通路,其中19例采用利福平浸泡的PTFE原位替换,3例直接修复。
  • 2例脓毒症合并感染性假性动脉瘤破裂者行结扎,2例无法挽救者转为自体动静脉瘘。
  • 7例(占挽救通路的1/3)分期行中心静脉狭窄腔内治疗。
  • 30天内1例死亡;所有修订通路保持通畅并用于透析(5例立即,19例4-5周内,2例静脉成熟后)。
  • 20例检测中9例(45%)血培养或出血部位培养阳性。

临床怎么用

  • 对通路出血患者应评估感染、管壁完整性和静脉高压,并考虑原位移植物替换以挽救通路。
  • 合并中心静脉狭窄者可分期行腔内治疗以维持通路功能。

局限性

  • 回顾性研究,样本量小(26例),单中心经验,结论需更大样本验证。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Hemorrhage from a dialysis access can be a life-threatening condition. This study details our experience using access rescue strategies, including in situ graft replacement, primary repair, or conversion to an autogenous fistula, coupled with treatment of central vein occlusion to maintain access usage in patients presenting with conduit hemorrhage. METHODS: During a 3-year period (2012-2014), 26 patients (14 women, 12 men) on chronic hemodialysis were treated for access conduit bleeding (n = 18) or life-threatening hemorrhage (n = 8), located in the upper extremity (n = 23) or thigh (n = 3). All patients had developed bleeding from a skin eschar/ulcer over a bovine (n = 9) or polytetrafluoroethylene (n = 9) bridge graft, or aneurysmal autogenous fistula (n = 8). A retrospective review of outcome relative to clinical signs, etiology of conduit bleeding (infection, wall erosion), and the type of rescue procedure(s) was performed. Duplex ultrasound testing was used to guide therapy based on the presence of aneurysmal degeneration, perigraft fluid, or access flow pattern indicative of venous outflow obstruction. RESULTS: One-half of the patients were taken emergently to the operating room for hemorrhage control or impending rupture of an infected false aneurysm, the remaining repaired on an urgent basis. In 18 patients, emergency room personnel attempted control of access site bleeding by suturing (n = 14) or tourniquet (n = 4). Dialysis access salvage was achieved in 22 (85%) of 26 patients by in situ conduit replacement using a rifampin-soaked polytetrafluoroethylene conduit (n = 19) or primary repair (n = 3). Two patients with sepsis and ruptured, infected false aneurysm were treated by ligation, and 2 patients with nonsalvable access had conversion to an autogenous fistula. One-third of rescued accesses (n = 7) had staged endovascular treatment of central vein stenosis. One patient died within 30 days. All dialysis access revisions remained patent and used for immediate dialysis (n = 5), within 4-5 weeks (n = 19), or after vein maturation (n = 2). One replaced graft was revised for infection. Positive blood or bleeding site cultures were obtained from 9 (45%) of 20 patients tested. CONCLUSIONS: Salvage of a functional dialysis access is possible in the majority of patients presenting with conduit hemorrhage. Loss of wall integrity, infection, and venous hypertension were etiologic factors. Application of in situ graft replacement strategies known to be effective in the treatment of graft infection should be considered in the management of this surgical emergency.

来源:Ann Vasc Surg,查看原文。版权归原作者所有。

引用

  1. Inui T, Boulom V, Bandyk D, et al. Dialysis Access Hemorrhage: Access Rescue from a Surgical Emergency. Ann Vasc Surg. 2017. PMID: 28341509. doi:10.1016/j.avsg.2017.03.003

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。